Aeglea Bio Therapeutics Inc (NASDAQ:AGLE)

4.20
Delayed Data
As of 3:58pm ET
 -0.17 / -3.89%
Today’s Change
3.47
Today|||52-Week Range
8.79
-11.58%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Shanafelt Armen B
Director
Buy12/09/2021121,799$3.67$447.0K+16.02%
Alspaugh Jonathan D
Chief Financial Officer
Buy12/09/202150,000$3.72$186.0K+16.02%
Quinn Anthony G
President & Chief Executive Officer
Buy12/09/202143,108$3.70$159.5K+16.02%
Alspaugh Jonathan D
Chief Financial Officer
Buy8/17/202123,392$6.50$152.0K-35.58%
Alspaugh Jonathan D
Chief Financial Officer
Buy8/16/20219,780$6.37$62.3K-34.78%
Shanafelt Armen B
Director
Buy12/13/202114,685$3.65$53.6K+11.41%
Shanafelt Armen B
Director
Buy12/10/202113,516$3.65$49.3K+12.90%
Alspaugh Jonathan D
Chief Financial Officer
Buy8/18/20217,200$6.72$48.4K-38.69%
Quinn Anthony G
President & Chief Executive Officer
Buy12/10/202110,526$3.75$39.5K+12.90%